FBIOP Fortress Biotech Inc Series A P

Watchlist

5.204
-0.016-0.31%

Close Nov 27 16:00 ET

262.59MMarket Cap0.00P/E (TTM)

About Fortress Biotech Inc Series A P Company

Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.

Company Profile

SymbolFBIOP

Company NameFortress Biotech Inc Series A P

Listing DateDec 19, 2011

Founded2006

CEODr. Lindsay A. Rosenwald, M.D.

MarketNASDAQ

Employees186

Fiscal Year Ends12-31

Address1111 Kane Concourse,Suite 301

CityBay Harbor Islands

ProvinceFlorida

CountryUnited States of America

Zip Code33154

Phone1-781-652-4500

Websitehttp://www.fortressbiotech.com

Company Executives

Name
Position
Salary

Dr. Lindsay A. Rosenwald, M.D.
Chairman of the Board, President and Chief Executive Officer
1.12M

David Jin
Principal Accounting Officer, Chief Financial Officer and Head, Corporate Development; Interim Chief Financial Officer and Chief Operating Officer of Avenue Therapeutics
1.32M

Dr. George C. Avgerinos, PhD
Senior Vice President, Biologics Operations
--

Michael S. Weiss
Director and Executive Vice Chairman, Strategic Development
962.66K

Dr. Eric K. Rowinsky,M.D.
Co-Vice Chairman and Director
175.07K

Dr. Lucy Lu, M.D.
Director
40.03K

J. Jay Lobell
Independent Director
87.57K

Dov Klein
Independent Director
120.06K

Malcolm Hoenlein
Independent Director
45.03K

Kevin L. Lorenz, J.D.
Independent Director
40.03K

Dr. Jimmie Harvey, Jr,M.D.
Independent Director
67.57K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data